Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of AUD 2.89 billion. The enterprise value is 2.90 billion.

Market Cap	2.89B
Enterprise Value	2.90B

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Mesoblast has 1.29 billion shares outstanding. The number of shares has increased by 14.51% in one year.

Current Share Class	1.29B
Shares Outstanding	1.29B
Shares Change (YoY)	+14.51%
Shares Change (QoQ)	+1.47%
Owned by Insiders (%)	32.66%
Owned by Institutions (%)	26.87%
Float	859.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	176.21
PS Ratio	29.50
PB Ratio	3.36
P/TBV Ratio	327.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-20.49
EV / Sales	29.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-31.89

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.24.

Current Ratio	1.58
Quick Ratio	1.35
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-2.23
Interest Coverage	-3.17

Financial Efficiency

Return on equity (ROE) is -18.22% and return on invested capital (ROIC) is -6.82%.

Return on Equity (ROE)	-18.22%
Return on Assets (ROA)	-6.16%
Return on Invested Capital (ROIC)	-6.82%
Return on Capital Employed (ROCE)	-10.82%
Weighted Average Cost of Capital (WACC)	9.44%
Revenue Per Employee	1.21M
Profits Per Employee	-1.75M
Employee Count	81
Asset Turnover	0.09
Inventory Turnover	3.86

Taxes

In the past 12 months, Mesoblast has paid 844,050 in taxes.

Income Tax	844,050
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.94% in the last 52 weeks. The beta is 0.90, so Mesoblast's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-8.94%
50-Day Moving Average	2.61
200-Day Moving Average	2.33
Relative Strength Index (RSI)	37.97
Average Volume (20 Days)	3,102,783

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mesoblast had revenue of AUD 98.02 million and -141.48 million in losses. Loss per share was -0.11.

Revenue	98.02M
Gross Profit	-34.83M
Operating Income	-106.11M
Pretax Income	-140.64M
Net Income	-141.48M
EBITDA	-96.46M
EBIT	-106.11M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 194.86 million in cash and 202.61 million in debt, giving a net cash position of -7.75 million or -0.01 per share.

Cash & Cash Equivalents	194.86M
Total Debt	202.61M
Net Cash	-7.75M
Net Cash Per Share	-0.01
Equity (Book Value)	861.57M
Book Value Per Share	0.67
Working Capital	111.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -89.42 million and capital expenditures -1.49 million, giving a free cash flow of -90.91 million.

Operating Cash Flow	-89.42M
Capital Expenditures	-1.49M
Free Cash Flow	-90.91M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is -35.53%, with operating and profit margins of -108.25% and -144.33%.

Gross Margin	-35.53%
Operating Margin	-108.25%
Pretax Margin	-143.47%
Profit Margin	-144.33%
EBITDA Margin	-98.40%
EBIT Margin	-108.25%
FCF Margin	n/a

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.51%
Shareholder Yield	-14.51%
Earnings Yield	-4.89%
FCF Yield	-3.14%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mesoblast has an Altman Z-Score of 3.45 and a Piotroski F-Score of 4.

Altman Z-Score	3.45
Piotroski F-Score	4